|
" Experimental and applied immunotherapy / "
Jeffrey Medin, Daniel Fowler, editors.
| Document Type
|
:
|
BL
|
| Record Number
|
:
|
1030993
|
| Doc. No
|
:
|
b785363
|
| Title & Author
|
:
|
Experimental and applied immunotherapy /\ Jeffrey Medin, Daniel Fowler, editors.
|
| Publication Statement
|
:
|
New York :: Humana Press,, ©2011.
|
| Page. NO
|
:
|
1 online resource (xvii, 442 pages) :: illustrations (some color)
|
| ISBN
|
:
|
1607619806
|
|
|
:
|
: 9781607619802
|
|
|
:
|
1607619792
|
|
|
:
|
9781607619796
|
| Bibliographies/Indexes
|
:
|
Includes bibliographical references and index.
|
| Contents
|
:
|
T cell therapy: state-of-the-art -- Extending the use of adoptive T cell immunotherapy for infections and cancer -- Non-T cell therapeutic approaches -- B lymphocytes in cancer immunology -- Monoclonal antibody therapy for cancer -- Natural killer cells for cancer immunotherapy -- Dendritic cell-based cancer vaccines: practical considerations -- Mesenchymal stromal cells: an emerging cell-based pharmaceutical -- T cell therapeutic approaches -- Tumor-specific mutations as targets for cancer immunotherapy -- Counteracting subversion of MHC class II antigen presentation by tumors -- Mechanisms and implications of immunodominance in CD8 T-cell responses -- T regulatory cells and cancer immunotherapy -- Negative regulators in cancer immunology and immunotherapy -- Genetically engineered antigen specificity in T cells for adoptive immunotherapy -- Non-cellular aspects of cancer immunotherapy -- Cytokine immunotherapy -- Transcriptional modulation using histone deacetylase inhibitors for cancer immunotherapy -- Combining cancer vaccines with conventional therapies -- Combining oncolytic viruses with cancer immunotherapy -- Radiation therapy and cancer treatment: from the basics to combination therapies that ignite immunity -- Assessing immunotherapy through cellular and molecular imaging -- Transplantation -- Allogeneic and autologous transplantation therapy of cancer: converging themes.
|
| Abstract
|
:
|
Immunotherapy is now recognized as an essential component of treatment for a wide variety of cancers. It is an interdisciplinary field that is critically dependent upon an improved understanding of a vast network of cross-regulatory cellular populations and a diversity of molecular effectors; it is a leading example of translational medicine with a favorable concept-to-clinical-trial timeframe of just a few years. There are many established immunotherapies already in existence, but there are exciting new cancer immunotherapies just on the horizon, which are likely to be more potent, less toxic.
|
| Subject
|
:
|
Immunotherapy.
|
| Subject
|
:
|
Cancer Vaccines-- therapeutic use.
|
| Subject
|
:
|
Immunotherapy-- methods.
|
| Subject
|
:
|
Neoplasms-- immunology.
|
| Subject
|
:
|
Neoplasms-- therapy.
|
| Subject
|
:
|
T-Lymphocytes-- immunology.
|
| Subject
|
:
|
HEALTH FITNESS-- Diseases-- Cancer.
|
| Subject
|
:
|
Immunotherapy.
|
| Subject
|
:
|
MEDICAL-- Oncology.
|
| Dewey Classification
|
:
|
616.07/9
|
| LC Classification
|
:
|
RM275.E97 2011
|
| NLM classification
|
:
|
2011 C-413
|
|
|
:
|
QZ 266
|
| Added Entry
|
:
|
Fowler, Daniel H.
|
|
|
:
|
Medin, Jeffrey.
|
| |